Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
Open Access
- 19 April 2021
- journal article
- research article
- Published by Elsevier BV in European Urology Open Science
- Vol. 28, 9-16
- https://doi.org/10.1016/j.euros.2021.03.008
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Complications After Systematic, Random, and Image-guided Prostate BiopsyEuropean Urology, 2016
- Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled TrialEuropean Urology, 2016
- Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12‐core biopsy resultsBJU International, 2016
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2European Urology, 2015
- Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic ReviewEuropean Urology, 2015
- Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-A 10-year population-based cohort studyThe Prostate, 2015
- Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancerLaboratory Investigation, 2015
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upThe Lancet, 2014
- Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific AntigenEuropean Urology, 2013
- Prognostic value of the Gleason score in prostate cancerBJU International, 2002